| 000 | 01072 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250518040149.0 | ||
| 008 | ####s 0 0 eng d | ||
| 022 | _a1476-5594 | ||
| 024 | 7 |
_a10.1038/s41388-019-0826-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHepburn, A C | |
| 245 | 0 | 0 |
_aCorrection: The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance. _h[electronic resource] |
| 260 |
_bOncogene _cMay 2019 |
||
| 300 |
_a4425 p. _bdigital |
||
| 500 | _aPublication Type: Published Erratum | ||
| 700 | 1 | _aSteele, R E | |
| 700 | 1 | _aVeeratterapillay, R | |
| 700 | 1 | _aWilson, L | |
| 700 | 1 | _aKounatidou, E E | |
| 700 | 1 | _aBarnard, A | |
| 700 | 1 | _aBerry, P | |
| 700 | 1 | _aCassidy, J R | |
| 700 | 1 | _aMoad, M | |
| 700 | 1 | _aEl-Sherif, A | |
| 700 | 1 | _aGaughan, L | |
| 700 | 1 | _aMills, I G | |
| 700 | 1 | _aRobson, C N | |
| 700 | 1 | _aHeer, R | |
| 773 | 0 |
_tOncogene _gvol. 38 _gno. 22 _gp. 4425 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41388-019-0826-2 _zAvailable from publisher's website |
| 999 |
_c29670702 _d29670702 |
||